Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study

BACKGROUND: White matter hyperintensities (WMHs) are commonly seen on in brain imaging and are associated with stroke and cognitive decline. Therefore, they may provide a relevant intermediate outcome in clinical trials. WMH can be measured as a volume or visually on the Fazekas scale. We investigat...

Descripción completa

Detalles Bibliográficos
Autores principales: Chappell, Francesca M., del Carmen Valdés Hernández, Maria, Makin, Stephen D., Shuler, Kirsten, Sakka, Eleni, Dennis, Martin S., Armitage, Paul A., Muñoz Maniega, Susana, Wardlaw, Joanna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320698/
https://www.ncbi.nlm.nih.gov/pubmed/28222778
http://dx.doi.org/10.1186/s13063-017-1825-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320698/
https://www.ncbi.nlm.nih.gov/pubmed/28222778
http://dx.doi.org/10.1186/s13063-017-1825-7

Ejemplares similares